Article
Sponsored Content
Emergent BioSolutions provides contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid and lyophilized products. Emergent’s sterile injectable manufacturing facility (located in Baltimore, MD) currently produces 20 commercial products and since 1998 has contributed to the development and production of over 200 clinical products.
Emergent BioSolutions
INTERPHEX Booth #1240
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.